Format
Sort by

Send to

Choose Destination

Search results

Items: 18

1.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group..

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897.

PMID:
27995656
2.

Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia.

Schneider A, Gottrand F, Bellaiche M, Becmeur F, Lachaux A, Bridoux-Henno L, Michel JL, Faure C, Philippe P, Vandenplas Y, Dupont C, Breton A, Gaudin J, Lamireau T, Muyshont L, Podevin G, Viola S, Bertrand V, Caldari D, Colinet S, Wanty C, Sauleau E, Leteurtre E, Michaud L.

Ann Surg. 2016 Dec;264(6):1004-1008.

PMID:
26720426
3.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group..

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466.

PMID:
26549003
4.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group..

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763.

PMID:
24162591
5.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group..

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889.

PMID:
22271569
6.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group..

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050.

PMID:
21708105
7.

Longitudinal study of bone mineral density in children after a diagnosis of Crohn's disease.

Samson F, Cagnard B, Leray E, Guggenbuhl P, Bridoux-Henno L, Dabadie A.

Gastroenterol Clin Biol. 2010 Oct;34(10):554-61. doi: 10.1016/j.gcb.2010.01.024.

8.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group..

Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.

PMID:
19837455
9.

[Value of transient elastography in noninvasive assessment in children's hepatic fibrosis].

Breton E, Bridoux-Henno L, Guyader D, Daniélou H, Jouan H, Beuchée A, Nousbaum JB, Dabadie A.

Arch Pediatr. 2009 Jul;16(7):1005-10. doi: 10.1016/j.arcped.2009.03.021. French.

PMID:
19446446
10.

AIRE gene analysis in children with autoimmune hepatitis type I or II.

Lankisch TO, Mourier O, Sokal EM, Habes D, Lacaille F, Bridoux-Henno L, Hermeziu B, Lenaerts C, Strassburg CP, Jacquemin E.

J Pediatr Gastroenterol Nutr. 2009 Apr;48(4):498-500. doi: 10.1097/MPG.0b013e31818550de.

PMID:
19322061
11.

Effect of a gluten-free diet on bone mineral density in children with celiac disease.

Heyman R, Guggenbuhl P, Corbel A, Bridoux-Henno L, Tourtelier Y, Balençon-Morival M, de Kerdanet M, Dabadie A.

Gastroenterol Clin Biol. 2009 Feb;33(2):109-14. doi: 10.1016/j.gcb.2008.09.020.

12.

[Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease].

Cagnard B, Tosoni-Verlingue D, Tribut O, Moizard C, Bridoux-Henno L, Delaperriere N, Bentue-Ferrer D, Dabadie A.

Arch Pediatr. 2006 Oct;13 Suppl 1:S67-8. French. No abstract available.

PMID:
17370399
13.

[Breastfeeding and vegan diet].

Wagnon J, Cagnard B, Bridoux-Henno L, Tourtelier Y, Grall JY, Dabadie A.

J Gynecol Obstet Biol Reprod (Paris). 2005 Oct;34(6):610-2. French.

14.

[Bone mineral density and Crohn's disease].

Cagnard B, Guggenbuhl P, Sorea S, Bridoux-Henno L, De Kerdanet M, LeGall E, Dabadie A.

Arch Pediatr. 2004 Dec;11(12):1513-4. French. No abstract available.

PMID:
15596346
15.

Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody.

Bridoux-Henno L, Maggiore G, Johanet C, Fabre M, Vajro P, Dommergues JP, Reinert P, Bernard O.

Clin Gastroenterol Hepatol. 2004 Sep;2(9):825-30.

PMID:
15354284
16.

Successful endoscopic drainage of a pancreatic pseudocyst in a 17-month-old boy.

Bridoux-Henno L, Dabadie A, Rambeau M, Gall EL, Bretagne JF.

Eur J Pediatr. 2004 Aug;163(8):482-4.

PMID:
15150658
17.

[Hemorrhagic colitis in exclusively breast-fed infants].

Sorea S, Dabadie A, Bridoux-Henno L, Balançon-Morival M, Jouan H, Le Gall E.

Arch Pediatr. 2003 Sep;10(9):772-5. French.

PMID:
12972203
18.

A case of celiac disease presenting with autoimmune hepatitis and erythroblastopenia.

Bridoux-Henno L, Dabadie A, Briard D, Bahon-Riedinger I, Jouan H, Le Gall E.

J Pediatr Gastroenterol Nutr. 2001 Nov;33(5):616-9. No abstract available.

PMID:
11740240
Items per page

Supplemental Content

Loading ...
Support Center